No increased heart failure risk is reported with DPP-4 inhibitors

BMJ. 2016 Apr 25:353:i2363. doi: 10.1136/bmj.i2363.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects*
  • Heart Failure / chemically induced*
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Risk

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents